Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Conditions: Hormone Receptor Positive Breast Carcinoma; Breast Neoplasms; Neoplasms, Breast; Breast Diseases; Antineoplastic Agents; Aromatase Inhibitors; ESR1 Gene Mutation Intervention: Diagnostic Test: Liquid biopsy and CT scan Sponsor: Centro di Riferimento Oncologico - Aviano Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | PET Scan | Research